Valueclick ( VCLK) estimates, target increased at UBS. VCLK estimates were raised through 2012. Acquisition should add to earnings. Neutral rating and new $16 price target. Veeco Instruments ( VECO) increased at UBS through 2012. Company is realizing higher orders. Buy rating and new $65 price target. Watson Pharmaceuticals ( WPI) estimates raised at Credit Suisse. WPI 2011 and 2012 EPS estimates raised to $4.20 and $5.37, respectively. Solid volumes and pricing should drive better than expected 1Q results, Credit Suisse said. Maintain Outperform rating and $65 price target. End of report.